Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series

by Payam Amini, Amir Almasi-Hashiani, Mohammad Ali Sahraian, Masood Najafi, Sharareh Eskandarieh
Published 2021-06-01

Comparison of Sleep Quality in Women with Migraine Moreover, Multiple Sclerosis

by Rozita Jalilian, Mahsa Ghajarzadeh, Rouzbeh Fateh, Mansoureh Togha, Mohammad Ali Sahraian, Amirreza Azimi
Published 2014-09-01

The Evaluation of Multiple Sclerosis Dispersal in Iran and Its Association with Urbanization, Life Style and Industry

by Rouhullah DEHGHANI, Masoud YUNESIAN, MohammadAli SAHRAIAN, HamidReza GILASI, Vahid KAZEMI-MOGHADDAM
Published 2015-10-01

Anxiety in Patients with Multiple Sclerosis: Association with Disability, Depression, Disease Type and Sex

by Fariba Askari, Mahsa Ghajarzadeh, Mehdi Mohammadifar, Amirreza Azimi, Mohammad Ali Sahraian, Mahsa Owji
Published 2014-12-01

Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns.

by Zahra Salehi, Rozita Doosti, Masoumeh Beheshti, Ehsan Janzamin, Mohammad Ali Sahraian, Maryam Izad
Published 2016-01-01

The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis

by Mostafa Almasi, Mohammad Ali Sahraian, Fahimeh Haji Akhoundi, Hamid Reza Ezzati, Mohammad Rohani
Published 2021-01-01

Age at menarche and risk of multiple sclerosis (MS): a systematic review and meta-analysis

by Amirreza Azimi, Sara Hanaei, Mohammad Ali Sahraian, Mehdi Mohammadifar, Sreeram V. Ramagopalan, Mahsa Ghajarzadeh
Published 2019-11-01

Relationship between sleep quality and quality of life in patients with multiple sclerosis

by Payam Sarraf, Sepeher Azizi, Abdorreza Naser Moghaddasi, Mohammad Ali Sahraian, Abbas Tafakhori, Mahsa Ghajarzadeh
Published 2014-01-01

The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder

by Zhila Maghbooli, Abdorreza Naser Moghadasi, Nasim Rezaeimanesh, Abolfazl Omidifar, Tarlan Varzandi, Mohammad Ali Sahraian
Published 2021-04-01

A focus on allogeneic mesenchymal stromal cells as a versatile therapeutic tool for treating multiple sclerosis

by Ameneh Shokati, Abdorreza Naser Moghadasi, Mohsen Nikbakht, Mohammad Ali Sahraian, Seyed Asadollah Mousavi, Jafar Ai
Published 2021-07-01

Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease

by Solaleh Emamgholipour, Seyede Mahdieh Eshaghi, Arash Hossein-nezhad, Khadijeh Mirzaei, Zhila Maghbooli, Mohammad Ali Sahraian
Published 2014-01-01

Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease

by Solaleh Emamgholipour, Seyede Mahdieh Eshaghi, Arash Hossein-nezhad, Khadijeh Mirzaei, Zhila Maghbooli, Mohammad Ali Sahraian
Published 2013-01-01

Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease.

by Solaleh Emamgholipour, Seyede Mahdieh Eshaghi, Arash Hossein-nezhad, Khadijeh Mirzaei, Zhila Maghbooli, Mohammad Ali Sahraian
Published 2013-01-01

Characterization of CD4+ and CD8+ T Cell Subsets and Interferon Regulatory Factor 4 (IRF4) in MS Patients Treated with Fingolimod (FTY-720): A Follow-up Study

by Bahare Laribi, Mohammad Ali Sahraian, Mehdi Shekarabi, Rahimeh Emamnejad, Mohsen Marzban, Shokufeh Sadaghiani, Maryam Izad
Published 2018-08-01

Reply to Urbanization Theory for Growing Trend of Multiple Sclerosis Letter

by Rouhullah DEHGHANI, Mohammad Ali SAHRAIAN, Masoud YUNESIAN, Mostafa HADEII, Hamid Reza GILASI, Vahid KAZEMI-MOGHADDAM
Published 2017-11-01

SCCmec Genotypes of Methicillin-Resistant Staphylococcus aureus in Nasal Carriage of Multiple Sclerosis Patients in Iran

by Yasaman JAMSHIDI, Mohammad Reza POURMAND, Zahra PAKBAZ, Amirhossein POURMAND, Abbas RAHIMI FOROUSHANI, Mohammad Ali SAHRAIAN
Published 2019-12-01

Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.

by Solaleh Emamgholipour, Seyede Mahdieh Eshaghi, Arash Hossein-nezhad, Khadijeh Mirzaei, Zhila Maghbooli, Mohammad Ali Sahraian
Published 2013-01-01

Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.

by Solaleh Emamgholipour, Seyede Mahdieh Eshaghi, Arash Hossein-nezhad, Khadijeh Mirzaei, Zhila Maghbooli, Mohammad Ali Sahraian
Published 2014-01-01

Widespread Disruptions of White Matter in Familial Multiple Sclerosis: DTI and NODDI Study

by Zeinab Gharaylou, Mohammad Ali Sahraian, Mahmoudreza Hadjighassem, Mohsen Kohanpour, Rozita Doosti, Shima Nahardani, Abdorreza Naser Moghadasi
Published 2021-08-01

Significant Increase in the Prevalence of Multiple Sclerosis in Iran in 2011

by Sadegh Izadi, Alireza Nikseresht, Maryam Sharifian, Mohammad Ali Sahraian, Alireza Hamidian Jahromi, Mohammad Aghighi, Alireza Heidary
Published 2014-03-01